{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+3%29&page=15", "query": { "intervention": "Placebo (Cohort 3)", "page": 15 }, "page_size": 10 }, "pagination": { "page": 15, "page_size": 10, "total_count": 1069, "total_pages": 107, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+3%29&page=16&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+%28Cohort+3%29&page=14&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T17:24:46.067Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05118386", "title": "Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "RSV Infection" ], "interventions": [ { "name": "RSM01", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Gates Medical Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 56, "start_date": "2021-11-16", "completion_date": "2022-12-07", "has_results": true, "last_update_posted_date": "2024-05-20", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05118386" }, { "nct_id": "NCT03955666", "title": "A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Safety" ], "interventions": [ { "name": "PRV-3279 or placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Provention Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 16, "start_date": "2019-08-07", "completion_date": "2019-12-11", "has_results": false, "last_update_posted_date": "2023-08-28", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03955666" }, { "nct_id": "NCT01874366", "title": "Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Overweight", "Diabetes Mellitus Type 2 in Obese" ], "interventions": [ { "name": "P11187", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Piramal Enterprises Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 96, "start_date": "2013-06", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2014-08-28", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01874366" }, { "nct_id": "NCT04208178", "title": "Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced HER2+Breast Cancer" ], "interventions": [ { "name": "Alpelisib", "type": "DRUG" }, { "name": "Alpelisib matching Placebo", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Pertuzumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 19, "start_date": "2020-07-16", "completion_date": "2027-02-26", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 2, "location_summary": "Fayetteville, Arkansas • Los Angeles, California", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04208178" }, { "nct_id": "NCT03041025", "title": "Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Scleroderma, Systemic" ], "interventions": [ { "name": "GSK2330811", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 35, "start_date": "2017-06-05", "completion_date": "2020-07-07", "has_results": true, "last_update_posted_date": "2021-05-24", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 6, "location_summary": "Los Angeles, California • Stanford, California • Chicago, Illinois + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03041025" }, { "nct_id": "NCT05747924", "title": "Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "FSHD", "FSHD1", "FSHD2", "FMD", "FMD2", "Fascioscapulohumeral Muscular Dystrophy", "Fascioscapulohumeral Muscular Dystrophy Type 1", "Fascioscapulohumeral Muscular Dystrophy Type 2", "Dystrophies, Facioscapulohumeral Muscular", "Dystrophy, Facioscapulohumeral Muscular", "Facioscapulohumeral Muscular Dystrophy 1", "Facioscapulohumeral Muscular Dystrophy 2", "Facio-Scapulo-Humeral Dystrophy", "Atrophy, Facioscapulohumeral", "Atrophies, Facioscapulohumeral", "Facioscapulohumeral Atrophy", "Muscular Dystrophies", "Muscular Dystrophy, Facioscapulohumeral", "FSH Muscular Dystrophy", "Landouzy Dejerine Dystrophy", "Landouzy-Dejerine Muscular Dystrophy", "Dystrophies, Landouzy-Dejerine", "Dystrophy, Landouzy-Dejerine", "Landouzy-Dejerine Syndrome", "Muscular Dystrophy, Landouzy Dejerine", "Progressive Muscular Dystrophy", "FSH" ], "interventions": [ { "name": "AOC 1020", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Avidity Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "16 Years to 70 Years" }, "enrollment_count": 90, "start_date": "2023-04-04", "completion_date": "2026-03-20", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 14, "location_summary": "Los Angeles, California • Palo Alto, California • San Diego, California + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05747924" }, { "nct_id": "NCT02354170", "title": "Short-Term Oral Mifepristone for Central Serous Chorioretinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Central Serous Chorioretinopathy" ], "interventions": [ { "name": "Mifepristone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roger Goldberg, M.D., MBA", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2015-01", "completion_date": "2017-04-27", "has_results": false, "last_update_posted_date": "2017-07-26", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 2, "location_summary": "Walnut Creek, California • Boston, Massachusetts", "locations": [ { "city": "Walnut Creek", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02354170" }, { "nct_id": "NCT01250366", "title": "Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HCV (Genotype 1)" ], "interventions": [ { "name": "INX-08189", "type": "DRUG" }, { "name": "Placebo matching with INX-08189", "type": "DRUG" }, { "name": "Ribavirin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 70, "start_date": "2010-10", "completion_date": "2011-06", "has_results": false, "last_update_posted_date": "2012-07-12", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 3, "location_summary": "Los Angeles, California • Plymouth, Minnesota • San Antonio, Texas", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Plymouth", "state": "Minnesota" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01250366" }, { "nct_id": "NCT06072157", "title": "Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants", "Chronic Spontaneous Urticaria" ], "interventions": [ { "name": "AK006-IV", "type": "DRUG" }, { "name": "Placebo-IV", "type": "DRUG" }, { "name": "AK006-SC", "type": "DRUG" }, { "name": "Placebo-SC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allakos Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 136, "start_date": "2023-08-28", "completion_date": "2025-05-12", "has_results": false, "last_update_posted_date": "2025-06-03", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 19, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Scottsdale, Arizona + 16 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Encino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06072157" }, { "nct_id": "NCT07534657", "title": "A Study of JPH034 in Healthy Adult Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Health Adult Subjects" ], "interventions": [ { "name": "JPH034", "type": "DRUG" }, { "name": "Placebo Control", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "J-Pharma Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 40, "start_date": "2026-03-22", "completion_date": "2026-10-10", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-14T17:24:46.067Z", "location_count": 1, "location_summary": "Dilworth, Minnesota", "locations": [ { "city": "Dilworth", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07534657" } ] }